{
  "id": "mhgap#risk_safety_c19a341a",
  "content": "thoughts, disordered thinking, paranoia, aggressive,\nerratic, violent\nKhat Alertness, euphoria, and mild excitation Lethargy, depressed mode, irritability Khat users often spend a significant portion of the\nday chewing khat; consti-pation, risk of mental health\nproblems such as psychosis\nCannabis Normal pupils, red conjunctivae, delayed Depressed or labile mood, anxiety, irritability, sleep Increased risk of mental health problems including\nresponsiveness, euphoria, relaxation disturbance (there may not be any clearly observable anxiety, paranoia and psychosis, lack of motivation,\nfeatures) difficulty in concentration, increased risk of vasospasm\nleading to myocardial infarction and stroke\nTramadol Opioid effects (sedation, euphoria, etc.) followed by Predominantly opioid withdrawal effects but also some Opioid dependence, risk of seizures, disturbed sleep\nstimulant effects (excitation and in high doses seizures serotonin norepinephrine reuptake inhibitor (SNRI)\nwithdrawal symptoms (depressed mood, lethargy)\nVolatile solvents Dizziness, disorientation, euphoria, light-headedness, Increased susceptibility to seizures Decreased cognitive function and dementia, peripheral\nincreased mood, hallucinations, delusions, incoord- neuropathy, other neurological sequelae, increased risk of\nination, visual disturbances, anxiolysis, sedation arrythmias causing sudden death\nHallucinogens Increased heart rate, blood pressure, body temperature, No evidence Acute or chronic psychotic episodes, flashbacks or re-\ndecreased appetite, nausea, vomiting, motor experiencing of drug effects long after termination of use",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "stress",
      "coping_skill",
      "risk_safety",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety thoughts, disordered thinking, paranoia, aggressive,\nerratic, violent\nKhat Alertness, euphoria, and mild excitation Lethargy, depressed mode, irritability Khat users often spend a significant portion of the\nday chewing khat; consti-pation, risk of mental health\nproblems such as psychosis\nCannabis Normal pupils, red conjunctivae, delayed Depressed or labile mood, anxiety, irritability, sleep Increased risk of mental health problems including\nresponsiveness, euphoria, relaxation disturbance (there may not be any clearly observable anxiety, paranoia and psychosis, lack of motivation,\nfeatures) difficulty in concentration, increased risk of vasospasm\nleading to myocardial infarction and stroke\nTramadol Opioid effects (sedation, euphoria, etc.) followed by Predominantly opioid withdrawal effects but also some Opioid dependence, risk of seizures, disturbed sleep\nstimulant effects (excitation and in high doses seizures serotonin norepinephrine reuptake inhibitor (SNRI)\nwithdrawal symptoms (depressed mood, lethargy)\nVolatile solvents Dizziness, disorientation, euphoria, light-headedness, Increased susceptibility to seizures Decreased cognitive function and dementia, peripheral\nincreased mood, hallucinations, delusions, incoord- neuropathy, other neurological sequelae, increased risk of\nination, visual disturbances, anxiolysis, sedation arrythmias causing sudden death\nHallucinogens Increased heart rate, blood pressure, body temperature, No evidence Acute or chronic psychotic episodes, flashbacks or re-\ndecreased appetite, nausea, vomiting, motor experiencing of drug effects long after termination of use Thoughts, disordered thinking, paranoia, aggressive,\nerratic, violent\nkhat alertness, euphoria, and mild excitation lethargy, depressed mode, irritability khat users often spend a significant portion of the\nday chewing k..."
}